CONTACT US: Contact info
|
Citation |
Ashraf AR, Mackey TK, Schmidt J, Kulcsár G, Vida RG, Li J, Fittler A. JAMA Netw. Open 2024; 7(8): e2428280. |
|
Copyright |
(Copyright © 2024, American Medical Association) |
|
DOI |
|
PMID |
unavailable |
|
Abstract |
The popularity of branded semaglutide is surging, with widespread media coverage, viral social media exposure, and celebrity endorsements.1 Although Wegovy (Novo Nordisk) is approved for long-term weight management, Ozempic (Novo Nordisk) (only approved for type 2 diabetes) is often used off-label for this purpose. Global regulatory agencies, including the US Food and Drug Administration (FDA), European Medicines Agency, and World Health Organization (WHO), have warned about fake versions driven by patient demand, high cost, and shortages. Illegal online pharmacies, which operate without valid licenses and sell medicines like semaglutide without prescription, represent a consumer risk for ineffective and dangerous products. ... |